A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
2013 ◽
Vol 16
(5)
◽
pp. 443-450
◽
2020 ◽
Vol Volume 13
◽
pp. 423-431
◽
2019 ◽
Vol 21
(10)
◽
pp. 2327-2332
◽
2011 ◽
Vol 94
(2)
◽
pp. 217-224
◽